Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
about
Development of a mechanism-based pharmacokinetic/pharmacodynamic model to characterize the thermoregulatory effects of serotonergic drugs in mice.Behavioral Changes Over Time Following Ayahuasca Exposure in ZebrafishEffect of Hallucinogens on Unconditioned Behavior.A Single Dose of 5-MeO-DMT Stimulates Cell Proliferation, Neuronal Survivability, Morphological and Functional Changes in Adult Mice Ventral Dentate Gyrus
P2860
Behavioral and pharmacokinetic interactions between monoamine oxidase inhibitors and the hallucinogen 5-methoxy-N,N-dimethyltryptamine.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@ast
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@en
type
label
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@ast
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@en
prefLabel
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@ast
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@en
P2860
P1476
Behavioral and pharmacokinetic ...... ethoxy-N,N-dimethyltryptamine.
@en
P2093
Adam L Halberstadt
P2860
P356
10.1016/J.PBB.2016.01.005
P407
P577
2016-01-15T00:00:00Z